$CTRV Taking a broader look brokerage firms’ analysts on the street with an expectant view have Contravir Pharmaceut (NASDAQ:CTRV) high price target of $4 and with a conservative view have low price target of $4. CTRV
Maxim Group “Initiates Coverage on” Contravir Pharmaceut (NASDAQ:CTRV) in a research note issued to investors on 5/06/16 to Buy.
Contravir Pharmaceut (NASDAQ:CTRV) shares traded 16.4% up during most recent session to reach at the closing price of $0.29.Analysts Alert: Contravir Pharmaceut (CTRV) ExpertGazette - 2d ago
Contravir Pharmaceut (NASDAQ:CTRV) shares traded 16.4% up during most recent session to reach at the closing price of $0.29.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.